Quart Barry D Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$1.11M
Insider Sells Quantity
5
Insider Sells Sum
$9.91M

Insider Activity of Quart Barry D

According to the SEC Form 4 filings, Quart Barry D, being in a position of

  1. director at Kiniksa Pharmaceuticals International, plc,
    оver the last 12 months, has bought 0 shares, and sold 58779 shares for $2.68M,
    over all time since 2022-11-29, has bought 0 shares, and sold 108186 shares for $3.87M.

Biography of Quart Barry D

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,679,5497100

Comparison of Insiders on Amount of Buys and Sells

2026-04-28SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
13,099
0.0164%
$50.10$656,260+39.42%
2026-04-06SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
6,901
0.0094%
$50.00$345,050+30.23%
2026-02-12SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
2,690
0.0037%
$45.00$121,050+33.05%
2026-02-04SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
2,602
0.0037%
$45.02$117,142+35.86%
2026-02-03SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
12,528
0.0172%
$45.27$567,143+31.49%
2026-02-02SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
830
0.0011%
$45.00$37,350+31.77%
2025-12-15SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
20,129
0.0274%
$41.51$835,555+29.28%
2025-06-11SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
12,336
0.017%
$30.39$374,891+36.5%
2025-06-10SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
8,212
0.0115%
$30.36$249,316+38.19%
2025-06-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
6,900
0.0094%
$30.26$208,794+35.58%
2022-11-29SaleKiniksa Pharmaceuticals, Ltd.
KNSA
director
21,959
0.0318%
$16.15$354,638-6.46%
2019-10-03PurchaseHeron Therapeutics, Inc.
HRTX
Chief Executive Officer
9,142
0.0046%
$8.75$79,993-8.03%
2018-06-21SaleHeron Therapeutics, Inc.
HRTX
Chief Executive Officer
100,000
0.0837%
$24.05$2.4M-32.09%
2018-03-19SaleHeron Therapeutics, Inc.
HRTX
Chief Executive Officer
200,000
0.2091%
$18.48$3.69M+9.71%
2018-03-14SaleHeron Therapeutics, Inc.
HRTX
Chief Executive Officer
200,000
0.2224%
$15.97$3.19M+34.91%
2015-03-02SaleHeron Therapeutics, Inc.
HRTX
Chief Executive Officer
20,000
0.0667%
$13.07$261,454+95.57%
2014-06-25PurchaseHeron Therapeutics, Inc.
HRTX
Chief Executive Officer
20,000
0.0832%
$11.75$235,000-19.42%
2013-11-20PurchaseHeron Therapeutics, Inc.
HRTX
Chief Executive Officer
2M
0.5755%
$0.40$800,000+14.48%
Total: 18
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.